What actually causes a dog's pancreas to produce too much insulin?

Insulinoma arises from neoplastic beta cells within the islets of Langerhans, the insulin-producing tissue scattered through the pancreas. These abnormal cells keep secreting insulin regardless of the dog's actual blood glucose level, and because normal feedback hormones like glucagon and cortisol cannot shut the tumor down, glucose gets driven steadily into the body's tissues until circulating blood sugar drops far below the normal range of roughly 80 to 120 mg/dL (Merck Veterinary Manual, 2023).

Approximately 40 to 50 percent of canine insulinomas have already metastasized to regional lymph nodes or the liver by the time of diagnosis, which is part of why the disease is considered malignant even when it looks like a single, discrete mass on imaging (American College of Veterinary Internal Medicine, 2022). No specific genetic mutation or environmental trigger has been consistently identified, and the tumor is not linked to diet or obesity the way some other endocrine conditions are.

The condition is most common in large-breed, middle-aged to older dogs, typically between 6 and 12 years old, with Labrador Retrievers, Golden Retrievers, Boxers, German Shepherd Dogs, and Irish Setters reported more frequently in retrospective case series (Cornell Riney Canine Health Center, 2023). Small and toy breeds can develop insulinoma, but it is reported far less often in dogs under 20 pounds.

What are the first warning signs owners typically notice at home?

The hallmark sign is episodic hypoglycemia, and because insulinoma cells secrete insulin unpredictably, episodes can appear and disappear over weeks or months before an owner connects the dots. Early signs are often subtle: brief lethargy, a wobbly gait after exercise, or a dog that seems oddly disoriented for a few minutes before acting completely normal again (Merck Veterinary Manual, 2023).

As blood glucose drops further, more dramatic neurologic signs appear, including muscle tremors, collapse, disorientation, and generalized seizures, since the brain depends almost entirely on circulating glucose for fuel. Some owners report their dog acting 'drunk' or bumping into furniture right before a full collapse episode, and these events frequently occur after exercise, excitement, or a period of fasting when glucose demand outpaces what the liver can replace.

Because symptoms are intermittent, many dogs are initially misdiagnosed with epilepsy, vestibular disease, or simple fainting spells before insulinoma is confirmed, and owners often report the pattern for months before a veterinarian catches a low reading during an episode (Cornell Riney Canine Health Center, 2023).

How do veterinarians confirm an insulinoma diagnosis?

Diagnosis starts with documenting hypoglycemia, ideally a blood glucose reading below 60 mg/dL captured during or shortly after a clinical episode, since a single low reading alone does not confirm insulinoma. Veterinarians then measure serum insulin concentration from that same blood draw; in a healthy dog, insulin should be suppressed when glucose is low, so a normal or elevated insulin level paired with hypoglycemia is the classic diagnostic combination known as an inappropriate insulin-to-glucose ratio (American College of Veterinary Internal Medicine, 2022).

Once bloodwork supports the diagnosis, abdominal ultrasound is used to try to visualize the pancreatic mass, though insulinomas are frequently small (often under 2 cm) and can be missed on ultrasound in a meaningful percentage of cases. CT scanning with contrast has become the preferred imaging tool at many referral centers because it detects smaller tumors and better evaluates lymph nodes and the liver for metastasis before surgery is planned (Cornell Riney Canine Health Center, 2023).

In many cases, exploratory surgery itself becomes both the final diagnostic step and the treatment, since surgeons can palpate and biopsy the pancreas directly and submit tissue for histopathology to confirm the tumor type and check surgical margins.

Is surgery the best treatment option, and what does recovery look like?

Surgical removal of the tumor, called partial pancreatectomy, along with any visibly affected lymph nodes, is generally recommended when the dog is a reasonable anesthetic candidate and the disease appears localized, because surgery offers the longest reported survival times. Median survival after surgery has been reported around 12 to 18 months in several case series, compared to roughly 3 to 8 months in dogs managed medically alone, though individual outcomes vary widely depending on how much metastasis is already present (American College of Veterinary Internal Medicine, 2022).

Post-surgical complications can include transient hyperglycemia, pancreatitis, and, less commonly, diabetes mellitus if too much normal pancreatic tissue is removed, so dogs are typically hospitalized for close glucose monitoring for several days after surgery. Even with successful tumor removal, most dogs eventually develop recurrent hypoglycemia as microscopic metastases progress, which is why owners are counseled that surgery manages rather than cures the disease in the majority of cases.

For dogs that are poor surgical candidates due to age, heart disease, or advanced metastasis, medical management alone is often pursued from the start, focusing on frequent small meals and drugs that blunt insulin's effect rather than trying to remove the tumor.

How is insulinoma managed day to day if a dog isn't a surgical candidate?

Dietary management centers on feeding small, frequent meals throughout the day, typically four to six times, with complex carbohydrates and added protein and fat to slow glucose absorption and avoid the rapid insulin spikes triggered by simple sugars or large single meals (Merck Veterinary Manual, 2023). Owners are usually instructed to avoid semi-moist treats and high-sugar snacks entirely, since sudden glucose spikes can actually worsen a subsequent insulin surge and drop blood sugar further.

When diet alone is not enough, prednisone is commonly added first because it raises blood glucose by promoting gluconeogenesis in the liver and reducing tissue sensitivity to insulin; doses are adjusted upward over time as tumors progress and hypoglycemia becomes harder to control. Diazoxide, a drug that directly inhibits insulin release from pancreatic cells and stimulates glucose production, is frequently layered in as a second-line medication when prednisone alone stops controlling clinical signs (American College of Veterinary Internal Medicine, 2022).

Owners are trained to keep glucose supplements such as corn syrup or a commercial dextrose gel on hand at all times, rubbing a small amount on the gums the moment they notice early wobbliness or disorientation, since acting within the first minute or two of a mild episode can often prevent a full seizure or collapse.

What is the long-term outlook for a dog diagnosed with insulinoma?

Because most canine insulinomas are malignant and a substantial proportion have already spread to lymph nodes or liver at diagnosis, insulinoma is not considered a curable disease in the large majority of dogs, even with aggressive surgery. Median survival times reported across veterinary literature range broadly, generally 6 months to just over a year with combined surgical and medical treatment, though a smaller subset of dogs with no detectable metastasis at surgery have lived considerably longer (American College of Veterinary Internal Medicine, 2022).

Regular rechecks of fasting blood glucose, typically every 1 to 3 months after diagnosis or surgery, allow veterinarians to catch rising hypoglycemia trends early and adjust medication or diet before a dog reaches crisis-level lows. Quality of life for many dogs remains good for months after diagnosis when episodes are caught early and managed proactively, which is why most veterinary oncologists frame treatment goals around comfort and stable glucose control rather than cure.

Are certain dog breeds or ages more likely to develop this tumor?

Insulinoma is overwhelmingly a disease of large-breed, middle-aged to senior dogs, with most affected dogs between 6 and 12 years old at diagnosis; it is rare in dogs under 5 years old and uncommon in toy or small breeds overall (Cornell Riney Canine Health Center, 2023). Labrador Retrievers, Golden Retrievers, Boxers, German Shepherd Dogs, and Irish Setters appear repeatedly in published case series, though any breed can be affected and no sex predisposition has been consistently demonstrated.

Because the tumor is uncommon in the general canine population, and no screening test is recommended for asymptomatic dogs, veterinarians typically only pursue insulinoma testing once a dog has shown a compatible clinical episode rather than as part of routine senior bloodwork panels.